Tech Company Financing Transactions

Neurotech Pharmaceuticals Funding Round

On 12/31/2009, Neurotech Pharmaceuticals raised $5.7 million in funding from Burrill & Company, SV Health Investors and Versant Ventures.

Transaction Overview

Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$5,700,100
Round
Undisclosed
Investors

Burrill & Company (Bryant Fong)

SV Health Investors (Lutz Giebel)

Versant Ventures (William Link)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
900 Highland Corporate Dr. Building 1 101
Lincoln, RI 02864
USA
Email Address
Overview
Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new medical therapies are the largest market opportunity in ophthalmology.
Profile
Neurotech Pharmaceuticals LinkedIn Company Profile
Social Media
Neurotech Pharmaceuticals Company Twitter Account
Company News
Neurotech Pharmaceuticals News
Facebook
Neurotech Pharmaceuticals on Facebook
YouTube
Neurotech Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Richard Small
  Richard Small LinkedIn Profile  Richard Small Twitter Account  Richard Small News  Richard Small on Facebook
VP - Bus. Development
Konrad Kauper
  Konrad Kauper LinkedIn Profile  Konrad Kauper Twitter Account  Konrad Kauper News  Konrad Kauper on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2009: Worksoft venture capital transaction
Next: 12/31/2009: Virxsys venture capital transaction

 

Share this article

 


News on VC Transactions

We document tech company VC transactions. VC investment data records on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary